Dr. Lazarides on Research Regarding Margin Assessment in Sarcoma

Video

Alexander Leandros Lazarides, MD, discusses research regarding margin assessment in patients with sarcoma.

Alexander Leandros Lazarides, MD, resident at Duke University Medical Center, discusses research regarding margin assessment in patients with sarcoma.

Negative surgical margins are associated with lower local recurrence and improved overall survival, explains Lazarides. However, it is only after surgery that the pathologist can evaluate a tumor sample to determine whether a negative margin was achieved or not. Results can take up to 2 weeks to return, at which point any residual disease that may have been left behind may have spread.

At Duke, investigators have developed an activatable fluorescent probe that has the potential to assess margins intraoperatively. The fluorescent probe is activated by cathepsin proteases, which are overexpressed in sarcoma, explains Lazarides. Once the primary tumor is taken out, surgeons can insert the probe to detect residual disease. This research has led to the development of a laser ablation system, which has been tested in mice as a way of killing remaining malignant cells, concludes Lazarides.

Related Videos
Christian Marth, MD, PhD, head, professor, Department of Obstetrics and Gynecology, Innsbruck Medical University
Mansoor Raza Mirza, MD, chief oncologist, Department of Oncology, Rigshospitalet, Copenhagen University Hospital
Judy Hayek, MD, gynecologic oncology fellow, State University of New York (SUNY) Downstate College of Medicine
Leslie M. Randall, MD, MAS, professor, division head, Department of Obstetrics and Gynecology – Gynecologic Oncology, Virginia Commonwealth University School of Medicine Obstetrics and Gynecology
Dimitrios Nasioudis, MD, fellow, Gynecologic Oncology, Perelman School of Medicine, the University of Pennsylvania
Sara Corvigno, MD, PhD, translational researcher, oncology, The University of Texas MD Anderson Cancer Center
I-Chia (Daniel) Liu, MD
Robert W. Mutter, MD
Saad J. Kenderian, MB, CHB, consultant, Division of Hematology, Department of Internal Medicine, Department of Immunology, Department of Molecular Medicine, assistant professor, oncology, immunology, medicine, Mayo Clinic
Mary-Ellen Taplin, MD